Hypertonic saline solution and high-dose furosemide infusion in cardiorenal syndrome: our experience

Hypertonic saline solution and high-dose furosemide infusion in cardiorenal syndrome: our experience

Introduction Heart failure is frequently complicated by renal failure, and this association is a negative prognostic factor. These patients sometimes present oligo-/anuria and resistance to high-dose furosemide, a condition referred to as the cardiorenal syndrome (CRS). Acute or chronic reductions i...

Full description

Bibliographic Details
Main Authors:	Francesco Ventrella, Sergio Cappello, Graziano Minafra, Maria Pipino, Mattea Carbone, Maria Insalata, Luigi Caccetta, Luigi Iamele
Format:	Article
Language:	English
Published:	PAGEPress Publications 2013-03-01
Series:	Italian Journal of Medicine
Subjects:	Heart failure Renal failure Hypertonic saline solution Furosemide Cardiorenal syndrome
Online Access:	http://www.italjmed.org/index.php/ijm/article/view/63

Similar Items

Evaluating the Effect of Adding Furosemide to Hypertonic Saline 5% on the Intracranial Pressure in Candidates of Craniotomy for Resection of Supratentorial Brain Tumors
by: Mehrdad Masoudifar, et al.
Published: (2018-08-01)

Use and performance of non-invasive ventilation in Internal Medicine ward: a real-life study
by: Francesco Ventrella, et al.
Published: (2015-01-01)

Effects of intravenous furosemide plus small‐volume hypertonic saline solutions on markers of heart failure
by: Antonino Tuttolomondo, et al.
Published: (2021-10-01)

The cardiorenal syndrome
by: Eric Klug
Published: (2017-04-01)

Cardiorenal syndrome in thalassemia patients
by: Sorasak Makmettakul, et al.
Published: (2020-08-01)

Subcutaneous Furosemide in Heart Failure
by: Domenic A. Sica, MD, et al.
Published: (2018-02-01)

The Diabetic Cardiorenal Nexus
by: John A. D’Elia, et al.
Published: (2022-07-01)

Furosemide continuous infusion versus repeated injection in the management of acute decompensated heart failure in infants with left to right shunt: a randomized trial
by: Marwa Zarzor, et al.
Published: (2023-10-01)

Causes of development and progression of cardiorenal syndrome in heart failure patients. Prevention methods
by: V. V. Davydov, et al.
Published: (2021-02-01)

Cardiorenal syndrome and diabetes: an evil pairing
by: Ana Belén Méndez Fernández, et al.
Published: (2023-05-01)

Furosemide and spironolactone doses and hyponatremia in patients with heart failure
by: Ivan Velat, et al.
Published: (2020-08-01)

Diuretic Resistance Treated with Low-Dose Hydralazine: A Case Report and Review of the Literature
by: Mohammed Alshehri, et al.
Published: (2021-08-01)

Heart failure in cardiorenal syndromes
by: E P Kharchenko
Published: (2013-01-01)

Prognostic Impact of the UMIPIC Program in the Follow Up in Patients with Heart Failure and Cardiorenal Syndrome
by: Manuel Méndez-Bailón, et al.
Published: (2023-11-01)

Editorial: New Advances in Cardiorenal Syndrome
by: Laurent Calvier, et al.
Published: (2022-07-01)

Avaliação laboratorial do uso de solução salina hipertônica e isotônica e de furosemida no tratamento da intoxicação por amônia em bovinos Laboratorial evaluation of hypertonic and isotonic saline solution and furosemide use for the ammonia poisoning treatment in cattle
by: Sandra Satiko Kitamura, et al.
Published: (2010-08-01)

Torsemide versus furosemide after acute decompensated heart failure: a retrospective observational study
by: Alaa Rahhal, et al.
Published: (2019-05-01)

A retrospective evaluation of the efficacy of intravenous bumetanide and comparison of potency with furosemide
by: Nappi JM
Published: (2013-03-01)

Editorial: Cardiorenal disease: a practical approach
by: Pedro Caravaca-Pérez, et al.
Published: (2024-02-01)

Cardiorenal syndrome in patients with chronic heart failure
by: L. A. Kovalevskaya, et al.
Published: (2015-08-01)

Hypertonic volume therapy: feasibility in the prevention and treatment of multiple organ failure and sepsis
by: Adhemar Monteiro Pacheco Jr., et al.

Psychosocial stress and quality of life in patients with type 2 cardiorenal syndrome
by: Elena BIVOL, et al.
Published: (2019-03-01)

Mitochondrial Dysfunction: An Emerging Link in the Pathophysiology of Cardiorenal Syndrome
by: Shuqing Shi, et al.
Published: (2022-02-01)

Association of early administration of furosemide with improved oxygenation in patients with acute heart failure
by: Takafumi Mikami, et al.
Published: (2021-08-01)

Galectin-3 as a Marker of Cardiorenal Syndrome in Patients with Chronic Heart Failure
by: V. I. Podzolkov, et al.
Published: (2022-05-01)

CARDIORENAL SYNDROME IN CHRONIC HEART FAILURE: PATHOGENESIS, DIAGNOSTICS, PROGNOSIS AND OPPORTUNITIES FOR TREATMENT
by: E. A. Medvedeva, et al.
Published: (2017-02-01)

Case report: Denosumab-associated acute heart failure in patients with cardiorenal insufficiency
by: Yuexian Xing, et al.
Published: (2022-09-01)

Safety and Efficacy of Adding Dapagliflozin to Furosemide in Type 2 Diabetic Patients With Decompensated Heart Failure and Reduced Ejection Fraction
by: Ayman Ibrahim, et al.
Published: (2020-12-01)

Furosemide is associated with acute kidney injury in critically ill patients
by: T.M. Levi, et al.
Published: (2012-09-01)

Furosemide is associated with acute kidney injury in critically ill patients
by: T.M. Levi, et al.
Published: (2012-09-01)

Continuous versus intermittent use of furosemide in patients with heart failure and moderate chronic renal dysfunction
by: Zhigui Zheng, et al.
Published: (2021-06-01)

Serum chloride and serum sodium derangements in children on prolonged furosemide therapy and their effect on diuretic response
by: Nanies Mohamed Salah EL Din Soliman, et al.
Published: (2022-10-01)

In dogs with congestive heart failure, is torasemide superior to furosemide as a first line diuretic treatment?
by: Leo Packham
Published: (2020-11-01)

A study of the efficacy of furosemide as a prophylaxis of acute renal failure in coronary artery bypass grafting patients: A clinical trial
by: Fatemeh Bayat, et al.
Published: (2015-05-01)

The cardiorenal problem
by: Emiliy Pollock, et al.
Published: (2014-11-01)

Clinical Significance of Apela in Acute Cardiorenal Insuffiency of Chronic Heart Failure
by: Yani Zong, et al.
Published: (2024-01-01)

Furosemide in Hypovolemic shock
by: Khalid Ali Khaleel
Published: (2020-12-01)

From Oral to Subcutaneous Furosemide: The Road to Novel Opportunities to Manage Congestion
by: Garima Dahiya, MD, et al.
Published: (2022-08-01)

Cardiorenal syndrome
by: Sabry Omar, et al.
Published: (2013-01-01)

Cardiorenal Crosstalk in Patients with Heart Failure
by: Sara Schukraft, et al.
Published: (2022-06-01)